David Weill
Director · TransMedics Group, Inc.
Individual
- 2025
- Sep 14, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Weill files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gerardo Hernandez - $1.25M in TMDX purchases and sales in the last 12 months
- Waleed H. Hassanein - $1.00M in TMDX purchases and sales in the last 12 months
- Thomas J. Gunderson - $722K in TMDX purchases and sales in the last 12 months
- Anil P. Ranganath - $556K in TMDX purchases and sales in the last 12 months
- Edward M. Basile - $540K in TMDX purchases and sales in the last 12 months
- Nicholas Corcoran - $413K in TMDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Weill?
David Weill is a corporate insider, tracked as Director of TransMedics Group, Inc. (TMDX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Weill submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has David Weill been buying or selling stock?
Recorded transactions: 1 open-market purchase ($109K) and 2 open-market sales ($1.22M) across all tracked filings.
